Potentiation of the action of fibroblast growth factor by heparin and related molecules.
Robinson
C J
CJ
National Institute for Biological Standards and Control, Potters Bar, Herts, U.K.
Ayling
C M
CM
Gray
E
E
Mulloy
B
B
D016475:3T3 Cells / Q000187:drug effects / Q000378:metabolism; D000818:Animals; D000925:Anticoagulants / Q000008:administration & dosage; D004247:DNA / Q000096:biosynthesis; D004357:Drug Synergism; D005346:Fibroblast Growth Factors / Q000008:administration & dosage*; D006493:Heparin / Q000008:administration & dosage*; D006495:Heparin, Low-Molecular-Weight / Q000008:administration & dosage; D051379:Mice; D011134:Polysaccharides / Q000008:administration & dosage
D000925:Anticoagulants; D006495:Heparin, Low-Molecular-Weight; D011134:Polysaccharides; D005346:Fibroblast Growth Factors; D006493:Heparin; D004247:DNA